• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Professional Introduction to 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde (CAS No: 1203988-32-2)

4-(3-fluoro-4-hydroxyphenyl)benzaldehyde, a compound with the chemical identifier CAS No: 1203988-32-2, is a significant molecule in the field of pharmaceutical chemistry and bioorganic synthesis. This aromatic aldehyde, characterized by its fluorine-substituted phenyl ring and a hydroxy group at the para position relative to the aldehyde functionality, has garnered considerable attention due to its versatile applications in drug discovery and molecular design.

The structural motif of 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde encompasses key pharmacophoric elements that make it a valuable intermediate in the synthesis of various therapeutic agents. The presence of both a fluorine atom and a hydroxyl group on the aromatic ring introduces unique electronic and steric properties, which can modulate the biological activity of derived compounds. Such features are particularly relevant in the development of small-molecule inhibitors targeting enzymes and receptors involved in critical biological pathways.

In recent years, the pharmaceutical industry has witnessed a surge in the use of fluorinated aromatic compounds due to their enhanced metabolic stability, improved binding affinity, and altered pharmacokinetic profiles. Among these, 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde stands out as a building block for designing molecules with potential applications in oncology, neurology, and anti-inflammatory therapies. Its role as a precursor in the synthesis of more complex scaffolds has been explored extensively in academic research.

One of the most compelling aspects of 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde is its utility in generating derivatives with tailored biological activities. For instance, researchers have leveraged this compound to develop novel kinase inhibitors, where the fluorine atom at the 3-position enhances interactions with the target protein's active site. Similarly, the hydroxyl group provides a handle for further functionalization via esterification or etherification reactions, enabling the creation of prodrugs or conjugates with improved solubility and bioavailability.

The synthesis of 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde typically involves multi-step organic transformations starting from commercially available precursors. Common synthetic routes include Friedel-Crafts acylation followed by selective reduction and subsequent halogenation or hydroxylation. These methodologies highlight the compound's synthetic accessibility, making it an attractive choice for both industrial-scale production and academic investigations.

The impact of fluorine substitution on the pharmacological properties of 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde derivatives has been well-documented in numerous studies. For example, fluorinated aromatic aldehydes have been shown to exhibit potent inhibitory effects against various kinases implicated in cancer progression. The electron-withdrawing nature of fluorine enhances hydrogen bonding interactions with hydrogen bond acceptors in protein active sites, thereby improving drug efficacy.

In addition to its role in kinase inhibition, 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde has found applications in developing antiviral agents. The combination of a hydroxyl group and a fluorine atom creates a scaffold that can interact with viral proteases or polymerases through specific hydrogen bonding networks. Recent advances in computational chemistry have further facilitated the design of optimized derivatives by predicting binding affinities and optimizing molecular geometry.

The growing interest in green chemistry principles has also influenced the synthesis of 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde. Researchers are increasingly adopting catalytic methods and solvent-free reactions to minimize waste generation and energy consumption. Such sustainable approaches align with global efforts to promote environmentally responsible chemical manufacturing while maintaining high yields and purity standards.

The versatility of 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde as a synthetic intermediate is further underscored by its use in fragment-based drug design. By employing this compound as a core structure, medicinal chemists can rapidly explore large chemical spaces without compromising on structural integrity or functional group compatibility. This strategy has proven particularly effective in identifying novel lead compounds with high therapeutic potential.

The future prospects for 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde are promising, given its broad applicability across multiple therapeutic areas. As computational tools continue to evolve, so too will our ability to predict and optimize derivatives with desired properties. Furthermore, interdisciplinary collaborations between chemists, biologists, and computer scientists will drive innovation by integrating experimental data with predictive modeling techniques.

In conclusion, 4-(3-fluoro-4-hydroxyphenyl)benzaldehyde (CAS No: 1203988-32-2) represents an essential component in modern pharmaceutical research and development. Its unique structural features—combining both fluorine substitution at position 3 and hydroxyl functionality at position 4—make it an invaluable intermediate for creating bioactive molecules with enhanced pharmacological properties. As synthetic methodologies advance toward greater efficiency and sustainability while computational tools become more sophisticated; this compound will undoubtedly remain at forefront innovation within medicinal chemistry landscape.

• 885964-91-0(3'-fluoro-4'-methoxy-[1,1'-biphenyl]-3-carbaldehyde)
• 1261978-62-4(3-(4-fluoro-3-hydroxyphenyl)benzaldehyde)
• 103438-85-3(4-Fluoro-3-hydroxybenzaldehyde)
• 405-05-0(3-Fluoro-4-hydroxybenzaldehyde)
• 544474-55-7(3-(2-Chloro-5-(trifluoromethyl)phenyl)benzaldehyde)
• 885473-84-7(4-(3-Fluoro-4-hydroxyphenyl)phenol)
• 716344-20-6([1,1'-Biphenyl]-4-carboxaldehyde,3'-fluoro-4'-methoxy-)
• 396-86-1(2-fluoro-4-(3-fluoro-4-hydroxyphenyl)phenol)
• 84376-21-6(2-fluoro-4-phenylphenol)
• 118276-06-5(3,5-Difluoro-4-hydroxybenzaldehyde)